9 July 2015 - Deborah Wilkes
Archived
The US Food and Drug Administration (FDA) plans to strengthen the cardiovascular warnings on non-steroidal anti-inflammatory drugs (NSAIDs), including OTC products. The revised warnings will not apply to aspirin.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.